5395232026-06-295395232026-06-292026-06-29539523ALKEM LABORATORIES LIMITEDALKEMNOTLISTEDINE540L01014Updatefalse2026-06-2900:41:002026-02-132026-03-062026-06-29Acquisition (including agreement to acquire)The Stock Exchanges were informed That M/s. Alkem Medtech Private Limited, a wholly owned subsidiary of the Company in India (“Alkem Medtech”), intends to acquire at least 51% and up to 55% of the total issued equity share capital of M/s. Occlutech Holding AG(“Occlutech”), a company incorporated in Switzerland and had executed Share Purchase Agreement with inter alia the selling shareholders of Occlutech.OthersWe wish to inform you that on 26th June, 2026, M/s. Alkem Medtech Private Limited has executed First Supplementary Agreement to Share Purchase Agreement dated 6th March, 2026 with inter alia the selling shareholders of Occlutech.